Mediators of immunity: lymphokines and monokines.

No abstract is available for this paper.

• Publication year

  1980

• Venue

  Advances in Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0065-2776(08)60043-7PMID 6158261
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Leucocyte migration inhibitory activity of concanavalin-A-stimulated lymphocytes. In vivo and in vitro modifications with dipyridamole and acetylsalicylic acid.

  2009cited by this paper
• Partial purification of a bone-resorbing factor elaborated from human allogeneic cultures.

  1979cited by this paper
• Determination of the human lymphokine leukocyte migration inhibitory factor (LIF) by a sensitive radioenzymatic assay. Inhibitory effect of cGMP on the esterolytic activity of highly purified LIF.

  1979cited by this paper
• Leukocyte migration inhibitory factor: a serine esterase released by stimulated human lymphocytes. Kinetic analysis and inhibition by cyclic GMP.

  1979cited by this paper
• Characterization of lymphocyte-activating factor (LAF) produced by human mononuclear cells: biochemical relationship of high and low molecular weight forms of LAF.

  1979cited by this paper
• Adherent cell function in murine T-lymphocyte antigen recognition. IV. Enhancement of murine T-cell antigen recognition by human leukocytic pyrogen

  1979cited by this paper
• Regulatory mechanisms in cell-mediated immune responses. VIII. Differential expression of I-region determinants by suppressor cells and their targets in suppression of mixed leukocyte reactions

  1979cited by this paper
• Physicochemical characterization of lymphocyte-activating factor (LAF).

  1979cited by this paper
• Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation

  1978cited by this paper
• Phorbol myristic acetate stimulates LAF production by the macrophage cell line, P388D.

  1978cited by this paper
• Characterization of lymphocyte-activating factor (LAF) produced by a macrophage cell line, P388D1. II. Biochemical characterization of LAF induced by activated T cells and LPS.

  1978cited by this paper
• Immune interferon II. Different cellular site for the production of murine macrophage migration inhibitory factor and interferon

  1978cited by this paper
• Possible role of macrophage glycolipids as receptors for migration inhibitory factor (MIF).

  1978cited by this paper
• Evidence for the identification of lymphocyte activating factor as the adherent cell-derived mediator responsible for enhanced antibody synthesis by nude mouse spleen cells.

  1978cited by this paper
• Pathogenesis of fever in delayed hypersensitivity: factors influencing release of pyrogen-inducing lymphokines

  1978cited by this paper
• Pathogenesis of fever in delayed hypersensitivity: role of monocytes

  1978cited by this paper
• Plasminogen activator of guinea pig basophilic leukocytes: probable localization to the plasma membrane.

  1978cited by this paper
• The relationship between bacterial endotoxin and human B cell-activating factor.

  1978cited by this paper
• Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages

  1978cited by this paper
• Human Leucocyte Migration Inhibitory Factor (LIF)

  1978cited by this paper
• An assay for human lymphocyte mitogenic factor: B-lymphocyte stimulation by a T-lymphocyte product.

  1978cited by this paper
• Partial characterization and purification of murine T cell-replacing factor, TRF. II. Biochemical characteristics.

  1978cited by this paper
• Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis.

  1978cited by this paper
• Delayed hypersensitivity in man: effects of systemic anticoagulation.

  1978cited by this paper
• Production of leucocyte migration inhibitory factor (LIF) in infectious mononucleosis. Spontaneous release and lack of response to concanavalin A.

  1978cited by this paper
• Lymphocyte-activating factor. I. Generation and physicochemical characterization.

  1978cited by this paper
• Secretion of lysosomal hydrolases by stimulated and nonstimulated macrophages

  1978cited by this paper
• The macrophage, target cell of the synthetic adjuvant muramyl dipeptide

  1978cited by this paper
• Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.

  1978cited by this paper
• The first component of complement. A quantitative comparison of its biosynthesis in culture by human epithelial and mesenchymal cells

  1978cited by this paper
• Increased production and expression of tissue thromboplastin-like procoagulant activity in vitro by allogeneically stimulated human leukocytes.

  1978cited by this paper
• Regulatory substances produced by lymphocytes. VI. Cell cycle specificity of inhibitor of DNA synthesis action in L cells

  1978cited by this paper
• Human migration inhibitory factor: purification and immunochemical characterization

  1978cited by this paper
• Characterization of suppressive immunoglobulin-binding factor (IBF). III. Biochemical and immunochemical characteristics of IBF produced by activated T cells.

  1978cited by this paper
• Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase, and plasminogen activator secretion and effects on other metabolic functions

  1978cited by this paper
• Human leukocyte inhibitory factor (LIF): use of benzoyl L-arginine ethyl ester to detect LIF activity.

  1978cited by this paper
• The induction of macrophage proliferation in vitro by a lymphocyte-produced factor.

  1978cited by this paper
• Elastase secretion by peritoneal exudative and alveolar macrophages

  1977cited by this paper
• Characterization of guinea pig mitogenic factors. I. Evidence that antigen-induced mitogenic factor and mitogenic factor from mixed leukocyte cultures are distinct molecular entities.

  1977cited by this paper
• Interferon action revisited

  1977cited by this paper
• Two migration inhibitory factors with different chromatographic behavior and isoelectric points.

  1977cited by this paper
• Macrophage plasminogen activator: induction by products of activated lymphoid cells

  1977cited by this paper
• Purification and properties of human lymphocyte activating factor (LAF).

  1977cited by this paper
• Synthesis and secretion of a mitogenic protein by macrophages: description of a superinduction phenomenon.

  1977cited by this paper
• The mechanism of action of soluble lymphocyte mediators. IV. Effect of migratio inhibitory factor (MIF) on macrophage cyclic AMP and on responsiveness to adenylate cyclase stimulators.

  1977cited by this paper
• Macrophages synthesise and release prostaglandins in response to inflammatory stimuli

  1977cited by this paper
• Lymphokine‐induced secretion of plasminogen activator by murine macrophages

  1977cited by this paper
• Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen-antibody complexes.

  1977cited by this paper
• Leukocyte migration in guinea pigs. II. Partial characterization of a leukocyte migration inhibitory factor distinct from macrophage migration inhibitory factor.

  1977cited by this paper
• Regulatory substances produced by lymphocytes--IV. Further characterization of the inhibitor of DNA synthesis (IDS).

  1977cited by this paper
• Target-cell membrane alterations induced by lymphotoxin. Ultrastructural observations.

  1977cited by this paper
• Eosinophils and immune mechanisms: V. Demonstration of mouse spleen cell-derived chemotactic activities for eosinophils and mononuclear cells and comparisons with eosinophil stimulation promoter☆

  1977cited by this paper
• Suppressive and enhancing T-cell factors as I-region gene products: properties and the subregion assignment.

  1977cited by this paper
• Immune interferon I. Production by lymphokine‐activated murine macrophages

  1977cited by this paper
• Human cells required for macrophage migration inhibitory factor (MIF) production.

  1977cited by this paper
• The mechanism of action of soluble lymphocyte mediators. V. Mechanism of refractoriness to adenylate cyclase stimulators induced by migration inhibitory factor (MIF).

  1977cited by this paper
• Chemotaxis of rat lymphocytes.

  1977cited by this paper
• Human Leukocyte Migration Inhibitory Factor (LIF)

  1977cited by this paper
• Separation of mitogen-induced suppressor and helper cell activities during inhibition of interferon production by cyclic AMP.

  1977cited by this paper
• Activation of T and B lymphocytes in vitro. VI. Biochemical and physicochemical characterization of the allogeneic effect factor.

  1977cited by this paper
• Antibodies against human lymphokines: I. Methods for induction of antibodies capable of neutralizing stable (alpha) and unstable (beta) lymphotoxins released in vitro by activated human lymphocytes.

  1977cited by this paper
• Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate.

  1977cited by this paper
• Characterization of suppressive immunoglobulin-binding factor (IBF). I. Production of IBF by a theta-positive lymphoma (L-5178-Y).

  1977cited by this paper
• Partial characterization of a T cell-derived factor that suppresses the initiation of the humoral immune response in vitro.

  1977cited by this paper
• Partial purification of human lymphocyte-activating factor (LAF) by ultrafiltration and electrophoretic techniques.

  1977cited by this paper
• Human Leukocyte Migration Inhibitory Factor (LIF)

  1977cited by this paper
• Regulatory substances produced by lymphocytes. V. Production of inhibitor of DNA synthesis (IDS) by proliferating T lymphocytes.

  1977cited by this paper
• Preparation of lymphocyte-activating factor from continuous murine macrophage cell lines.

  1977cited by this paper
• Cyclic AMP regulation of mitogen-induced interferon production and mitogen suppression of immune response

  1977cited by this paper
• Antibodies to guinea-pig lymphokines. V. Suppression of normal lymphocyte transfer, immune lymphocyte transfer and direct reactions in the guinea-pig by anti-lymphokine globulin.

  1977cited by this paper
• Synthesis of a fibrinolytic activator and inhibitor by endothelial cells.

  1977cited by this paper
• Production of the second component of complement by human monocytes: stimulation by antigen-activated lymphocytes or lymphokines

  1977cited by this paper
• Characterization of human chemotactic lymphokine production induced by mitogens and mixed leukocyte reactions using a new microassay.

  1977cited by this paper
• Human Leukocyte Migration Inhibitory Factor (LIF)

  1977cited by this paper
• Chemical treatment of macrophages increases their responsiveness to migration inhibitory factor (MIF).

  1977cited by this paper
• Blastogenic factors: production by T and B lymphocytes. Effect on T and B cells.

  1977cited by this paper
• Inhibition of human lymphocyte-mediated mitogen-induced cytotoxicity of murine L-929 cells by heterologous anti-human lymphotoxin antisera in vitro.

  1977cited by this paper
• T-T interactions in the induction of suppressor and helper T cells: analysis of membrane phenotype of precursor and amplifier cells

  1977cited by this paper
• The effect of PHA-activated MN-cell supernatants on polymorphonuclear leucocyte function.

  1977cited by this paper
• The production of heterologous antibodies to the human lymphakine: leukocyte migration inhibitory factor (LIF).

  1977cited by this paper
• Suppression of B cell MIF production by T cells and soluble T cell-derived factors.

  1977cited by this paper
• On the varied biologic effects of interferon.

  1977cited by this paper
• Human immunodeficiency disease: impairment of cellular interactions leading to abnormal mediator production in mixed lymphocyte culture reaction.

  1977cited by this paper
• Regulatory factors produced by lymphocytes. II. Inhibition of cellular DNA synthesis associated with a factor inhibiting DNA polymerase alpha activity.

  1977cited by this paper
• Human Leukocyte Migration Inhibitory Factor (LIF)

  1977cited by this paper
• Immunostimulators induce granulocyte/macrophage colony-stimulating activity and block proliferation in a monocyte tumor cell line

  1977cited by this paper
• Association of a low molecular weight helper factor(s) with thymocyte proliferative activity.

  1977cited by this paper
• Characterization of suppressive immunoglobulin-binding factor (IBF). II. Purification and molecular weight determination of IBF produced by L-5178-Y theta-positive lymphoma.

  1977cited by this paper
• Bidirectional amplification of macrophage-lymphocyte interactions: enhanced lymphocyte activation factor production by activated adherent mouse peritoneal cells.

  1977cited by this paper
• Big and little forms of osteoclast activating factor.

  1977cited by this paper
• Activation of T and B lymphocytes in vitro. V. Cellular locus, metabolism and genetics of induction, and production of the allogeneic effect factor.

  1977cited by this paper
• The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor

  1976cited by this paper
• Regulation of immunity and inflammation by mediators from macrophages.

  1976cited by this paper
• Ly phenotype of T-cells releasing T-cell replacing factor

  1976cited by this paper
• Control of lymphokine secretion by prostaglandins

  1976cited by this paper
• Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides.

  1976cited by this paper
• Antibodies to guinea pig lymphokines. III. Reactions with radiolabeled lymphocyte activation products

  1976cited by this paper
• Effect of anti-lymphotoxin on cell-mediated cytotoxicity. Evidence for two pathways, one involving lymphotoxin and the other requiring intimate contact between the plasma membranes of killer and target cells.

  1976cited by this paper
• Antigen-specific and nonspecific mediators of T cell/B cell cooperation. III. Characterization of the nonspecific mediator(s) from different sources.

  1976cited by this paper
• Partial characterization of murine migration inhibitory factor (MIF).

  1976cited by this paper

• Pathogenic contribution of the Macrophage migration inhibitory factor family to major depressive disorder and emerging tailored therapeutic approaches.

  2019cites this paper
• Impact of Salmonella Infection on Host Hormone Metabolism Revealed by Metabolomics

  2011cites this paper
• Involvement of monokines in antigen- and lectin-induced human lymphokine production.

  2009cites this paper
• Influence of autologous monocytes on the pokeweed mitogen-induced generation of immunoglobulin-secreting cells in man.

  2009cites this paper
• Immunologic specificity: solutions

  2009cites this paper
• Affinity-purified human Interleukin I is cytotoxic to isolated islets of Langerhans

  2006cites this paper
• Biochemical effects of KH 1060 and anti-TNF monoclonal antibody on human peripheral blood mononuclear cells.

  2005cites this paper
• Non-specific cell-mediated immunity in Nigerian children with uncomplicated malaria

  2005cites this paper
• Enhanced production of prostaglandins and plasminogen activator during activation of human articular chondrocytes by products of mononuclear cells

  2004cites this paper
• The role of lymphokines in delayed-type hypersensitivity reactions

  2004cites this paper
• Interleukin-1-like activities in synovial fluids of patients with rheumatoid arthritis and traumatic synovitis

  2004cites this paper
• Sensitization of human tumor cells to homologous complement by vaccinia virus treatment

  2004cites this paper
• Increased plasma levels of leukotriene B4 and prostaglandin E2 in cats experimentally inoculated with feline infectious peritonitis virus

  2004cites this paper
• Brief Definitive Report

  2003cites this paper
• ACTIVATION OF Fc RECEPTOR-BEARING LYMPHOCYTES BY IMMUNE COMPLEXES II. Killer Lymphocytes Mediate Fc Ligand-induced Lymphokine Production*

  2003cites this paper
• Synergistic inhibitory effect of cyclosporin A and vitamin D derivatives on T-lymphocyte proliferation in active ulcerative colitis

  2002cites this paper
• Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double‐blind placebo‐controlled trial

  2001cites this paper
• In vitro cytokine secretion in individuals with schizophrenia: results, confounding factors, and implications for further research.

  2001cites this paper
• The Effects of Ketorolac on T Cell Subsets in Patients Undergoing a Gastrectomy

  2001cites this paper
• Increased urinary leukotriene E4 and eosinophil protein X excretion in patients with interstitial cystitis.

  2001cites this paper
• Effects of sex hormones on production of interleukin-1 by human peripheral monocytes.

  1999cites this paper
• Aberrant cytokine regulation in macrophages from young autoimmune-prone mice: evidence that the intrinsic defect in MRL macrophage IL-1 expression is transcriptionally controlled.

  1995cites this paper
• Immune responsiveness of lambs selected for resistance to haemonchosis.

  1993cites this paper
• The potential role of cytokines in cancer therapy.

  1992cites this paper
• Inhibition of interferon-gamma- and phorbol ester-induced HLA-DR and interleukin-1 production by the expression of a transfected poly(ADP-ribose) synthetase gene in human leukemia THP-1 cells.

  1992cites this paper
• Monocyte adherence to fibronectin: role of CD11/CD18 integrins and relationship to other monocyte functions

  1992cites this paper
• Inhibition of interferon-γ- and phorbol ester-induced HLA-DR and interleukin-1 production by the expression of a transfected poly(ADP-ribose) synthetase gene in human leukemia THP-1 cells

  1992cites this paper
• Some cutaneous responses to mitogen injection in sheep, with special reference to eosinophil leucocytes.

  1991cites this paper
• The role of avian macrophages in the production of avian lymphokines.

  1990cites this paper
• Phagocyte function in juvenile periodontitis

  1990cites this paper
• Human T-cell mediated response to homologous lens antigen.

  1989cites this paper
• Mononuclear phagocytes.

  1989cites this paper
• Interferon-gamma activates multiple pathways to regulate the expression of the genes for major histocompatibility class II I-A beta, tumor necrosis factor and complement component C3 in mouse macrophages.

  1989cites this paper
• Inhibition by the LTD4 antagonist, SR2640, of effects of LTD4 on canine polymorphonuclear leukocyte functions.

  1989cites this paper
• Abnormal Variation of the Immune System as Related to Cancer

  1989cites this paper
• Cytokines in Relation to Inflammatory Skin Disease

  1989cites this paper
• The role of macrophages on the expression of sex difference in the susceptibility to Brugia pahangi infection in C57BL/6 mice

  1989cites this paper
• 6 – Immunological Specificity, Continued

  1989cites this paper
• Immune mechanisms in the pathogenesis of pulmonary tuberculosis.

  1989cites this paper
• Effects of gamma interferon on syntheses of DNA and proteins by Entamoeba histolytica

  1989cites this paper
• Production of a factor inhibiting tumor cell migration by spleen cells from tumor-bearing mice.

  1988cites this paper
• [Effects of prostaglandins on superoxide anion production by human neutrophils induced by Bacteroides gingivalis. II].

  1988cites this paper
• Generation, Biology, and Assay of Efferent Lymphokines

  1988cites this paper
• Biologicals produced from animal cells in culture--an overview.

  1988cites this paper
• Human Interleukin 1 Inhibitors

  1987cites this paper
• Bacterial Peptidoglycans and Host Defense

  1987cites this paper
• Isolation and initial characterization of multiple species of T-lymphocyte subset cDNA clones.

  1987cites this paper
• Idiopathic production of interleukin-1 in acquired immune deficiency syndrome

  1987cites this paper
• Islet Cytotoxicity of Interleukin 1: Influence of Culture Conditions and Islet Donor Characteristics

  1987cites this paper
• Leucocyte migration inhibition in diphtheria toxoid hypersensitivity

  1987cites this paper
• Immunomodulation following burn injury.

  1987cites this paper
• The mucosal regulation of the systemic immune response to cholera toxin.

  1987cites this paper
• Aberrant phagocyte function in Shwachman syndrome.

  1987cites this paper
• Divergent effects of human lymphokine derived oligopeptides on PMNLs function of young and aged healthy subjects.

  1987cites this paper
• Lymphokines

  1987cites this paper
• The role of extracellular proteases in cell proliferation and differentiation.

  1987cites this paper
• The HLA-IDDM association: implications for etiology and pathogenesis of IDDM.

  1987cites this paper
• Activation of B lymphocytes by Epstein‐Barr virus/CR2 receptor interaction

  1987cites this paper
• Molecular Biology of Interleukin 1

  1987cites this paper
• Detection of different macrophage-activating factor and interferon activities in supernatants of chicken lymphocyte cultures.

  1987cites this paper
• Effect of macrophage activators on the phagocytosis of mycobacteria by Schwann cells.

  1986cites this paper
• Fundamentals of Immunology

  1986cites this paper
• Concurrent enhancement of monocyte immunoregulatory properties and effector functions by recombinant interferon-gamma.

  1986cites this paper
• Postburn immunosuppression in an animal model. IV. Improved resistance to septic challenge with immunomodulating drugs.

  1986cites this paper
• Enhancement of non-specific antiviral defence mechanisms in NMRI-mice by cell culture mediators.

  1986cites this paper
• Novel neutrophil chemotactic factor derived from human peripheral blood mononuclear leucocytes.

  1986cites this paper
• Prevention of posttraumatic alterations in lymphocyte subpopulations in mice by immunomodulating drugs.

  1986cites this paper
• Biologicals from Animal Cells in Culture

  1986cites this paper
• Malnutrition and immunological function with special reference to cell‐mediated immunity

  1986cites this paper
• Role of Calomys musculinus peritoneal macrophages in age‐related resistance to junin virus infection

  1986cites this paper
• Mechanisms of Pancreatic Islet Cell Destruction Dose‐Dependent Cytotoxic Effect of Soluble Blood Mononuclear Cell Mediators on Isolated Islets of Langerhans

  1986cites this paper
• Detection of a polyoma virus-induced tumor-associated membrane antigen in mouse cells by the macrophage migration inhibition test.

  1986cites this paper
• Pertussigen enhances antigen-driven interferon-γ production by sensitized lymphoid cells

  1986cites this paper
• Lymphokine (MIF) production by glomerular T-lymphocytes in experimental glomerulonephritis.

  1986cites this paper
• Pertussigen enhances antigen-driven interferon-gamma production by sensitized lymphoid cells.

  1986cites this paper
• Monocyte factors modulate in vitro T-lymphocyte mitogenesis in protein malnutrition.

  1986cites this paper
• Prevention of alterations in postoperative lymphocyte subpopulations by cimetidine and ibuprofen.

  1986cites this paper
• Disease‐modifying antirheumatic drugs

  1985cites this paper
• Application of migration inhibition techniques in tumor immunology.

  1985cites this paper
• Identification of an immunosuppressive protein in bovine seminal plasma with activity against bovine lymphocytes.

  1985cites this paper
• Enhancement of Hamster Alveolar Macrophage Phagocytic Activity by Lymphokines

  1985cites this paper
• Human endothelial cell cultures: Phenotypic modulation by leukocyte interleukins

  1985cites this paper
• Chemical characterization of an interleukin-1-inducing substance derived from human mixed leukocyte reactions: IL-1-inducing substance is not gamma interferon.

  1985cites this paper
• Strong prostaglandin associated suppression of the proliferation of human maternal lymphocytes by neonatal lymphocytes linked to T versus T cell interactions and differential PGE2 sensitivity.

  1985cites this paper
• Receptor on Human Mononuclear Phagocytes

  1985cites this paper
• In vitro migration inhibition of [3H]leucine-labeled granulocytes by supernatants of Con A-Sepharose stimulated MNC cultures.

  1985cites this paper
• Eicosanoide und Phospholipasen

  1985cites this paper
• [Eicosanoids and phospholipases].

  1985cites this paper
• Cytokines Cause Functional and Structural Damage to Isolated Islets of Langerhans

  1985cites this paper
• Interleukins.

  1985cites this paper
• The role of arginase in the immune response.

  1985cites this paper
• Demonstration and partial characterization of the interferon-gamma receptor on human mononuclear phagocytes.

  1985cites this paper
• Erythropoietin production by macrophages in the regenerating liver

  1985cites this paper
• Contribution of Immune Interferon (IFN-γ) in Lymphokine-Induced Anti-Toxoplasma Activity: Studies with Recombinant Murine IFN-γ

  1985cites this paper
• Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus and in vitro properties

  1985cites this paper
• Contribution of immune interferon (IFN-gamma) in lymphokine-induced anti-toxoplasma activity: studies with recombinant murine IFN-gamma.

  1985cites this paper
• Cells and Tissues of Immunity

  1984cites this paper
• Pharmacologic modulation in vitro of human histamine-induced suppressor cell activity.

  1984cites this paper
• Modulation of lymphocyte migration by human lymphokines. III. Characterization of a lymphocyte migration inhibitory factor (LyMIF35K).

  1984cites this paper
• Leukocyte interleukins induce cultured endothelial cells to produce a highly organized, glycosaminoglycan-rich pericellular matrix

  1984cites this paper